BAY 2927088, an oral, reversible tyrosine kinase inhibitor (TKI) that potently inhibits mutant HER2, led to promising response rates when used for the treatment of patients with pretreated HER2 ...

Novo Nordisk's U.S.-listed shares lost ground Friday after a study of the pharmaceutical firm’s latest obesity treatment ...

Athira Pharma has been on a bumpy road in recent years, and now the company is restructuring and shedding weight to try to ...

The millage increase is needed because the overall cost of operating the county has increased, inflation is up and the portion the county pays for its part of health insurance for its employees is ...

Lincoln Equities Group debuted its speculative project 800 feet from the city's Global Container Marine Terminal, while Phase ...

The first phase of what eventually will be the country’s largest truck stop is set to open Oct. 1 off Interstate 90 in West ...

Tocilizumab -- an interleukin (IL)-6 receptor inhibitor -- was approved by the FDA in 2017 for the treatment of severe or ...

The first phase of the Jammu and Kashmir polls saw men outnumbering women in casting votes by over 4.79 percentage points, ...

Structure Therapeutics (NASDAQ:GPCR), and Terns Pharmaceuticals (NASDAQ:TERN), which are all developing oral pills as weight loss treatments, are trading higher Friday following disappointing results ...

NKT2152, a novel HIF2a inhibitor, demonstrates significant efficacy in patients with advanced clear cell renal cell carcinoma ...

The next morning, Sept. 16, Hawaiian Volcano Observatory scientists on a helicopter overflight confirmed that a small ...

Plus: LiquidStack raises $20 Million in Series B extension investment, HEST Investments secures $1.8 million SPV investment ...